[Exogenous psychosis in a patient with carcinoid syndrome following treatment with p-chlorophenylalanine (PCPA)].
A case is reported of a patient with carcinoid syndrome who developed a exogenous psychosis while under treatment with the serotonin-inhibitor p-chlorophenylalanine (PCPA). Partial symptoms similar to delirium and schizophrenia were exhibited. The attached literature survey focuses on the psychological side effects of PCPA treatment. A discussion follows concerning noteworthy phenomenological similarities between the case reported and certain forms of amphetamine psychosis. Common biochemical mechanisms are hypothetically stated.
D005260:Female; D010134:Fenclonine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008303:Malignant Carcinoid Syndrome / Q000188:drug therapy*; D008875:Middle Aged; D011605:Psychoses, Substance-Induced
D010134:Fenclonine
Exogene Psychose eines Patienten mit Karzinoidsyndrom nach Behandlung mit p-Chlorophenylalanin (PCPA)